Trial
NCT00748904
Rifaximin Versus Lactulose in Renal Failure
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
—
Condition
Liver Cirrhosis
Intervention
Rifaximin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-08